1. Home
  2. EMBC vs CYRX Comparison

EMBC vs CYRX Comparison

Compare EMBC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$3.06

Market Cap

524.1M

Sector

Health Care

ML Signal

HOLD

CYRX

CryoPort Inc.

HOLD

Current Price

$13.35

Market Cap

419.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMBC
CYRX
Founded
1924
1999
Country
United States
United States
Employees
N/A
1100
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
524.1M
419.3M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
EMBC
CYRX
Price
$3.06
$13.35
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$18.50
$13.31
AVG Volume (30 Days)
3.0M
596.4K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
6.88%
N/A
EPS Growth
20.90
156.22
EPS
0.67
N/A
Revenue
N/A
$176,177,000.00
Revenue This Year
$1.17
$11.06
Revenue Next Year
N/A
$8.45
P/E Ratio
$4.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.08
$5.31
52 Week High
$15.55
$13.79

Technical Indicators

Market Signals
Indicator
EMBC
CYRX
Relative Strength Index (RSI) 14.26 73.35
Support Level N/A $7.98
Resistance Level $9.51 $13.79
Average True Range (ATR) 0.38 0.69
MACD -0.32 0.11
Stochastic Oscillator 0.97 89.26

Price Performance

Historical Comparison
EMBC
CYRX

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

About CYRX CryoPort Inc.

CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.

Share on Social Networks: